{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:47:18Z","timestamp":1795085238761,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["C4045-18W"],"award-info":[{"award-number":["C4045-18W"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14105419"],"award-info":[{"award-number":["14105419"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["14104820"],"award-info":[{"award-number":["14104820"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007421","name":"Li Ka Shing Foundation","doi-asserted-by":"publisher","award":["Li Ka Shing Foundation"],"award-info":[{"award-number":["Li Ka Shing Foundation"]}],"id":[{"id":"10.13039\/100007421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002655","name":"Terry Fox Foundation","doi-asserted-by":"publisher","award":["Terry Fox Foundation"],"award-info":[{"award-number":["Terry Fox Foundation"]}],"id":[{"id":"10.13039\/501100002655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["AstraZeneca Research Program (2017)"],"award-info":[{"award-number":["AstraZeneca Research Program (2017)"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-022-00872-3","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T20:08:55Z","timestamp":1653077335000},"page":"834-847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver"],"prefix":"10.1038","volume":"19","author":[{"given":"Wenshu","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-6159","authenticated-orcid":false,"given":"Jingying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myth T. S.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhewen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Chun","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heung Man","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice C. H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard H. W.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W. H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4919-3707","authenticated-orcid":false,"given":"Ka Fai","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B. S.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3679-6368","authenticated-orcid":false,"given":"Kelvin K. C.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon K. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent W. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-6764","authenticated-orcid":false,"given":"Alice P. S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J. Y.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred S. L.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"872_CR1","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretanuby-Secretan","year":"2016","unstructured":"Lauby-Secretanuby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794\u20138. https:\/\/doi.org\/10.1056\/NEJMsr1606602","journal-title":"N Engl J Med"},{"key":"872_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019;15:139\u201354. https:\/\/doi.org\/10.1038\/s41574-018-0126-x","journal-title":"Nat Rev Endocrinol"},{"key":"872_CR3","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/1055-9965.EPI-12-0485","volume":"21","author":"W Demark-Wahnefriedmark-Wahnefried","year":"2012","unstructured":"Demark-Wahnefriedmark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, et al. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev. 2012;21:1244\u201359. https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-0485","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"872_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001","journal-title":"Metabolism"},{"key":"872_CR5","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringelngel","year":"2020","unstructured":"Ringelngel AE, Drijvers JM, Baker GJ, Catozzi A, Garc\u00eda-Ca\u00f1averas JC, Gassaway BM, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183:1848\u201366 e1826. https:\/\/doi.org\/10.1016\/j.cell.2020.11.009","journal-title":"Cell"},{"key":"872_CR6","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Wardrd","year":"2019","unstructured":"Wardrd ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381:2440\u201350. https:\/\/doi.org\/10.1056\/NEJMsa1909301","journal-title":"N Engl J Med"},{"key":"872_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossiunossi","year":"2018","unstructured":"Younossiunossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"872_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaranaskaran","year":"2014","unstructured":"Bhaskaranaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384:755\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(14)60892-8","journal-title":"Lancet"},{"key":"872_CR9","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3","journal-title":"Lancet"},{"key":"872_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","volume":"175","author":"M Grohmannrohmann","year":"2018","unstructured":"Grohmannrohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, et al. Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC. Cell. 2018;175:1289\u2013306 e1220. https:\/\/doi.org\/10.1016\/j.cell.2018.09.053","journal-title":"Cell"},{"key":"872_CR11","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","volume":"2018","author":"M Masaroneasarone","year":"2018","unstructured":"Masaroneasarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, et al. Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2018;2018:9547613. https:\/\/doi.org\/10.1155\/2018\/9547613","journal-title":"Oxid Med Cell Longev"},{"key":"872_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","volume":"16","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411\u201328. https:\/\/doi.org\/10.1038\/s41575-019-0145-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"872_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","volume":"27","author":"GN Ioannou","year":"2016","unstructured":"Ioannou GN. The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol Metab. 2016;27:84\u201395. https:\/\/doi.org\/10.1016\/j.tem.2015.11.008","journal-title":"Trends Endocrinol Metab"},{"key":"872_CR14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/hep.510250623","volume":"25","author":"D St\u00e5hlberg","year":"1997","unstructured":"St\u00e5hlberg D, Rudling M, Angelin B, Bj\u00f6rkhem I, Forsell P, Nilsell K, et al. Hepatic cholesterol metabolism in human obesity. Hepatology. 1997;25:1447\u201350. https:\/\/doi.org\/10.1002\/hep.510250623","journal-title":"Hepatology"},{"key":"872_CR15","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","volume":"15","author":"HK Min","year":"2012","unstructured":"Min HK, Kapoor A, Fuchs M, Mirshahi F, Zhou H, Maher J, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012;15:665\u201374. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.004","journal-title":"Cell Metab"},{"key":"872_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223\u201338. https:\/\/doi.org\/10.1038\/s41575-020-00381-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"872_CR17","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jhep.2015.07.009","volume":"63","author":"JC Hsiang","year":"2015","unstructured":"Hsiang JC, Wong GL-H, Tse Y-K, Wong VW-S, Yip TC-F, Chan HL-Y. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: a propensity score landmark analysis. J Hepatol. 2015;63:1190\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.009","journal-title":"J Hepatol"},{"key":"872_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/2326-6066.CIR-15-0062","volume":"3","author":"RM McEwen-Smith","year":"2015","unstructured":"McEwen-Smith RM, Salio M, Cerundolo V. The regulatory role of invariant NKT cells in tumor immunity. Cancer Immunol Res. 2015;3:425\u201335. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0062","journal-title":"Cancer Immunol Res"},{"key":"872_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao B, Radaeva S, Park O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J Leukoc Biol. 2009;86:513\u201328. https:\/\/doi.org\/10.1189\/JLB.0309135","journal-title":"J Leukoc Biol"},{"key":"872_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/cmi.2015.115","volume":"13","author":"K Bandyopadhyay","year":"2016","unstructured":"Bandyopadhyay K, Marrero I, Kumar V. NKT cell subsets as key participants in liver physiology and pathology. Cell Mol Immunol. 2016;13:337\u201346. https:\/\/doi.org\/10.1038\/cmi.2015.115","journal-title":"Cell Mol Immunol"},{"key":"872_CR21","doi-asserted-by":"publisher","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360. https:\/\/doi.org\/10.1126\/science.aan5931.","DOI":"10.1126\/science.aan5931"},{"key":"872_CR22","doi-asserted-by":"publisher","unstructured":"Yang W, Feng Y, Zhou J, Cheung OK-W, Cao J, Wang J, et al. A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma. Sci Transl Med. 2021;13. https:\/\/doi.org\/10.1126\/scitranslmed.aaz6804.","DOI":"10.1126\/scitranslmed.aaz6804"},{"key":"872_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41423-020-00534-2","volume":"18","author":"X Zeng","year":"2021","unstructured":"Zeng X, Zhou J, Xiong Z, Sun H, Yang W, Mok MTS, et al. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis. Cell Mol Immunol. 2021;18:1005\u201315. https:\/\/doi.org\/10.1038\/s41423-020-00534-2","journal-title":"Cell Mol Immunol"},{"key":"872_CR24","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1158\/0008-5472.CAN-14-3786","volume":"75","author":"Y Tian","year":"2015","unstructured":"Tian Y, Wong VW, Wong GL, Yang W, Sun H, Shen J, et al. Histone deacetylase HDAC8 promotes insulin resistance and beta-catenin activation in NAFLD-associated hepatocellular carcinoma. Cancer Res. 2015;75:4803\u201316. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3786","journal-title":"Cancer Res"},{"key":"872_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07402-8","volume":"9","author":"H Sun","year":"2018","unstructured":"Sun H, Yang W, Tian Y, Zeng X, Zhou J, Mok M, et al. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. Nat Commun. 2018;9:5214. https:\/\/doi.org\/10.1038\/s41467-018-07402-8","journal-title":"Nat Commun"},{"key":"872_CR26","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","volume":"69","author":"O Krenkel","year":"2020","unstructured":"Krenkel O, Hundertmark J, Abdallah AT, Kohlhepp M, Puengel T, Roth T, et al. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. Gut. 2020;69:551\u201363. https:\/\/doi.org\/10.1136\/gutjnl-2019-318382","journal-title":"Gut"},{"key":"872_CR27","doi-asserted-by":"publisher","first-page":"e0149948","DOI":"10.1371\/journal.pone.0149948","volume":"11","author":"L Yao","year":"2016","unstructured":"Yao L, Abe M, Kawasaki K, Akbar SMF, Matsuura B, Onji M, et al. Characterization of liver monocytic myeloid-derived suppressor cells and their role in a murine model of non-alcoholic fatty liver disease. PLoS ONE. 2016;11:e0149948. https:\/\/doi.org\/10.1371\/journal.pone.0149948","journal-title":"PLoS ONE"},{"key":"872_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1126\/scitranslmed.aba4448","volume":"12","author":"O Govaere","year":"2020","unstructured":"Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, et al. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis. Sci Transl Med. 2020;12:150. https:\/\/doi.org\/10.1126\/scitranslmed.aba4448","journal-title":"Sci Transl Med"},{"key":"872_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21:225\u201345. https:\/\/doi.org\/10.1038\/s41580-019-0190-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"872_CR30","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister D, Nunez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592:450\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03362-0","journal-title":"Nature"},{"key":"872_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ni.3437","volume":"17","author":"I Engel","year":"2016","unstructured":"Engel I, Seumois G, Chavez L, Samaniego-Castruita D, White B, Chawla A, et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat Immunol. 2016;17:728\u201339. https:\/\/doi.org\/10.1038\/ni.3437","journal-title":"Nat Immunol"},{"key":"872_CR32","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.celrep.2020.108116","volume":"32","author":"T Baranek","year":"2020","unstructured":"Baranek T, Lebrigand K, de Amat Herbozo C, Gonzalez L, Bogard G, Dietrich C, et al. High dimensional single-cell analysis reveals iNKT cell developmental trajectories and effector fate decision. Cell Rep. 2020;32:108116. https:\/\/doi.org\/10.1016\/j.celrep.2020.108116","journal-title":"Cell Rep"},{"key":"872_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2013.06.010","volume":"59","author":"T Kapanadze","year":"2013","unstructured":"Kapanadze T, Gamrekelashvili J, Ma C, Chan C, Zhao F, Hewitt S, et al. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma. J Hepatol. 2013;59:1007\u201313. https:\/\/doi.org\/10.1016\/j.jhep.2013.06.010","journal-title":"J Hepatol"},{"key":"872_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.144762","volume":"6","author":"Y Kawachi","year":"2021","unstructured":"Kawachi Y, Fujishima Y, Nishizawa H, Nakamura T, Akari S, Murase T, et al. Increased plasma XOR activity induced by NAFLD\/NASH and its possible involvement in vascular neointimal proliferation. JCI Insight. 2021;6:1. https:\/\/doi.org\/10.1172\/jci.insight.144762","journal-title":"JCI Insight"},{"key":"872_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","volume":"70","author":"X Zhang","year":"2021","unstructured":"Zhang X, Coker OO, Chu ES, Fu K, Lau HCH, Wang YX, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70:761\u201374. https:\/\/doi.org\/10.1136\/gutjnl-2019-319664","journal-title":"Gut"},{"key":"872_CR36","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1053\/j.gastro.2021.02.051","volume":"160","author":"D Liu","year":"2021","unstructured":"Liu D, Wong CC, Zhou Y, Li C, Chen H, Ji F, et al. Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target. Gastroenterology. 2021;160:2467\u201382 e2463. https:\/\/doi.org\/10.1053\/j.gastro.2021.02.051","journal-title":"Gastroenterology"},{"key":"872_CR37","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1158\/1078-0432.CCR-14-2422","volume":"21","author":"B Basu","year":"2015","unstructured":"Basu B, Dean E, Puglisi M, Greystoke A, Ong M, Burke W, et al. First-in-human pharmacokinetic and pharmacodynamic study of the dual m-TORC 1\/2 inhibitor AZD2014. Clin Cancer Res. 2015;21:3412\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2422","journal-title":"Clin Cancer Res"},{"key":"872_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku F, Yap TA, Meric-Bernstam F. Targeting the PI3K pathway in cancer: are we making headway? Nat Rev Clin Oncol. 2018;15:273\u201391. https:\/\/doi.org\/10.1038\/nrclinonc.2018.28","journal-title":"Nat Rev Clin Oncol"},{"key":"872_CR39","doi-asserted-by":"publisher","first-page":"11796","DOI":"10.1016\/S0021-9258(18)80136-3","volume":"264","author":"L Liscum","year":"1989","unstructured":"Liscum L, Faust JR. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem. 1989;264:11796\u2013806.","journal-title":"J Biol Chem"},{"key":"872_CR40","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3389\/fimmu.2018.01817","volume":"9","author":"H Schmid","year":"2018","unstructured":"Schmid H, Schneidawind C, Jahnke S, Kettemann F, Secker KA, Duerr-Stoerzer S, et al. Culture-expanded human invariant natural killer T cells suppress T-cell alloreactivity and eradicate leukemia. Front Immunol. 2018;9:1817. https:\/\/doi.org\/10.3389\/fimmu.2018.01817","journal-title":"Front Immunol"},{"key":"872_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12013-017-0799-0","volume":"75","author":"AW Girotti","year":"2017","unstructured":"Girotti AW, Korytowski W. Cholesterol hydroperoxide generation, translocation, and reductive turnover in biological systems. Cell Biochem Biophys. 2017;75:413\u20139. https:\/\/doi.org\/10.1007\/s12013-017-0799-0","journal-title":"Cell Biochem Biophys"},{"key":"872_CR42","doi-asserted-by":"publisher","first-page":"e1800311","DOI":"10.1002\/pmic.201800311","volume":"19","author":"GC Forcina","year":"2019","unstructured":"Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19:e1800311. https:\/\/doi.org\/10.1002\/pmic.201800311","journal-title":"Proteomics"},{"key":"872_CR43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/php.12969","volume":"95","author":"AW Girotti","year":"2019","unstructured":"Girotti AW, Korytowski W. Cholesterol peroxidation as a special type of lipid oxidation in photodynamic systems. Photochem Photobiol. 2019;95:73\u201382. https:\/\/doi.org\/10.1111\/php.12969","journal-title":"Photochem Photobiol"},{"key":"872_CR44","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, Sun X, Chen D, Zappasodi R, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity. 2021;54:1561\u201377 e1567. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.003","journal-title":"Immunity"},{"key":"872_CR45","doi-asserted-by":"publisher","unstructured":"Khan AA, Agarwal H, Reddy SS, Arige V, Natarajan B, Gupta V, et al. MicroRNA 27a Is a Key Modulator of Cholesterol Biosynthesis. Mol Cell Biol. 2020;40. https:\/\/doi.org\/10.1128\/MCB.00470-19.","DOI":"10.1128\/MCB.00470-19"},{"key":"872_CR46","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u201312 e1005. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.015","journal-title":"Cell Metab"},{"key":"872_CR47","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","volume":"158","author":"BA Neuschwander-Tetri","year":"2020","unstructured":"Neuschwander-Tetri BA. Therapeutic landscape for NAFLD in 2020. Gastroenterology. 2020;158:1984\u201398 e1983. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.051","journal-title":"Gastroenterology"},{"key":"872_CR48","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1053\/j.gastro.2021.02.051","volume":"160","author":"D Liu","year":"2021","unstructured":"Liu D, Wong CC, Zhou Y, Li C, Chen H, Ji F, et al. Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase 3 and is a therapeutic target. Gastroenterology. 2021;160:2467\u201382. https:\/\/doi.org\/10.1053\/j.gastro.2021.02.051","journal-title":"Gastroenterology"},{"key":"872_CR49","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1053\/j.gastro.2009.01.053","volume":"136","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Johnson ML, Hachem C, Morgana RO. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009;136:1601\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2009.01.053","journal-title":"Gastroenterology"},{"key":"872_CR50","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.canep.2014.06.009","volume":"38","author":"KA McGlynn","year":"2014","unstructured":"McGlynn KA, Divine GW, Sahasrabuddhe VV, Engel LS, VanSlooten A, Wells K, et al. Statin use and risk of hepatocellular carcinoma in a U.S. population. Cancer Epidemiol. 2014;38:523\u20137. https:\/\/doi.org\/10.1016\/j.canep.2014.06.009","journal-title":"Cancer Epidemiol"},{"key":"872_CR51","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1053\/j.gastro.2019.01.026","volume":"156","author":"DE Kaplan","year":"2019","unstructured":"Kaplan DE, Serper MA, Mehta R, Fox R, John B, Aytaman A, et al. Effects of hypercholesterolemia and statin exposure on survival in a large national cohort of patients with cirrhosis. Gastroenterology. 2019;156:1693\u2013706 e1612. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.026","journal-title":"Gastroenterology"},{"key":"872_CR52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2020.05.017","volume":"32","author":"NM LaMarche","year":"2020","unstructured":"LaMarche NM, Kane H, Kohlgruber AC, Dong H, Lynch L, Brenner MB. Distinct iNKT cell populations use IFNgamma or ER stress-induced IL-10 to control adipose tissue homeostasis. Cell Metab. 2020;32:243\u201358 e246. https:\/\/doi.org\/10.1016\/j.cmet.2020.05.017","journal-title":"Cell Metab"},{"key":"872_CR53","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf MJ, Adili A, Piotrowitz K, Abdullah Z, Boege Y, Stemmer K, et al. Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell. 2014;26:549\u201364. https:\/\/doi.org\/10.1016\/j.ccell.2014.09.003","journal-title":"Cancer Cell"},{"key":"872_CR54","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek M, Pfister D, Donakonda S, Filpe P, Schneider A, Laschinger M, et al. Auto-aggressive CXCR6(+) CD8 T cells cause liver immune pathology in NASH. Nature. 2021;592:444\u20139. https:\/\/doi.org\/10.1038\/s41586-021-03233-8","journal-title":"Nature"},{"key":"872_CR55","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132\u201341. https:\/\/doi.org\/10.1038\/s42255-020-0174-0","journal-title":"Nat Metab"},{"key":"872_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","volume":"30","author":"X Ma","year":"2019","unstructured":"Ma X, Bi E, Lu Y, Su P, Huang C, Liu L, et al. Cholesterol induces CD8(+) T cell exhaustion in the tumor microenvironment. Cell Metab. 2019;30:143\u201356 e145. https:\/\/doi.org\/10.1016\/j.cmet.2019.04.002","journal-title":"Cell Metab"},{"key":"872_CR57","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.20171576","volume":"215","author":"X Ma","year":"2018","unstructured":"Ma X, Bi E, Huang C, Lu Y, Xue G, Guo X, et al. Cholesterol negatively regulates IL-9-producing CD8(+) T cell differentiation and antitumor activity. J Exp Med. 2018;215:1555\u201369. https:\/\/doi.org\/10.1084\/jem.20171576","journal-title":"J Exp Med"},{"key":"872_CR58","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2013.11.031","volume":"60","author":"MS Matter","year":"2014","unstructured":"Matter MS, Decaens T, Andersen JB, Thorgeirsson SS. Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatol. 2014;60:855\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2013.11.031","journal-title":"J Hepatol"},{"key":"872_CR59","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fonc.2020.01510","volume":"10","author":"L Xue","year":"2020","unstructured":"Xue L, Qi H, Zhang H, Ding L, Huang Q, Zhao D, et al. Targeting SREBP-2-regulated mevalonate metabolism for cancer therapy. Front Oncol. 2020;10:1510 https:\/\/doi.org\/10.3389\/fonc.2020.01510","journal-title":"Front Oncol"},{"key":"872_CR60","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","volume":"176","author":"SH Moon","year":"2019","unstructured":"Moon SH, Huang CH, Houlihan SL, Regunath K, Freed-Pastor WA, Morris JP, et al. p53 represses the mevalonate pathway to mediate tumor suppression. Cell. 2019;176:564\u201380 e519. https:\/\/doi.org\/10.1016\/j.cell.2018.11.011","journal-title":"Cell"},{"key":"872_CR61","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ncb3355","volume":"18","author":"T Welte","year":"2016","unstructured":"Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632\u201344. https:\/\/doi.org\/10.1038\/ncb3355","journal-title":"Nat Cell Biol"},{"key":"872_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","volume":"67","author":"A Marengo","year":"2016","unstructured":"Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103\u201317. https:\/\/doi.org\/10.1146\/annurev-med-090514-013832","journal-title":"Annu Rev Med"},{"key":"872_CR63","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1096\/fj.201902069R","volume":"34","author":"D Tian","year":"2020","unstructured":"Tian D, Hong H, Shang W, Ho CC, Dong J, Tian XY. Deletion of Ppard in CD11c(+) cells attenuates atherosclerosis in ApoE knockout mice. FASEB J. 2020;34:3367\u201378. https:\/\/doi.org\/10.1096\/fj.201902069R","journal-title":"FASEB J"},{"key":"872_CR64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00872-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T15:25:06Z","timestamp":1669303506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-022-00872-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["872"],"URL":"https:\/\/doi.org\/10.1038\/s41423-022-00872-3","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JZ and ASLC received the funding support and drug (vistusertib) from AstraZeneca. VWSW has consultancy in 3V-BIO, AbbVie, Allergan, Boehringer Ingelheim, Center for Outcomes Research in Liver Diseases, Echosens, Gilead Sciences, Hanmi Pharmaceutical, Intercept, Inventiva, Merck, Novartis, Novo Nordisk, Perspectum Diagnostics, Pfizer, ProSciento, Sagimet Biosciences, TARGET PharmaSolutions and Terns; has lectures in Abbott, AbbVie, Bristol-Myers Squibb, Echosens, Gilead Sciences and Novo Nordisk; received research grants from Gilead Sciences; and holds stock as co-founder of Illuminatio Medical Technology Limited. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}